Evidence map›Paper›PMID 30332641›Full record

ArticleCell reports2018

Long-Term In Vitro Expansion of Epithelial Stem Cells Enabled by Pharmacological Inhibition of PAK1-ROCK-Myosin II and TGF-β Signaling.

Chengkang Zhang, Hyung Joo Lee, Anura Shrivastava, Ruipeng Wang, Travis J McQuiston, Sharon S Challberg, Brian A Pollok, Ting Wang

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Chengkang ZhangPropagenix, 9605 Medical Center Drive, Suite 325, Rockville, MD 20850, USA. Electronic address: ck.zhang@propagenix.com.
Hyung Joo LeeDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63108, USA; The Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63108, USA.
Anura ShrivastavaPropagenix, 9605 Medical Center Drive, Suite 325, Rockville, MD 20850, USA.
Ruipeng WangPropagenix, 9605 Medical Center Drive, Suite 325, Rockville, MD 20850, USA.
Travis J McQuistonPropagenix, 9605 Medical Center Drive, Suite 325, Rockville, MD 20850, USA.
Sharon S ChallbergPropagenix, 9605 Medical Center Drive, Suite 325, Rockville, MD 20850, USA.
Brian A PollokPropagenix, 9605 Medical Center Drive, Suite 325, Rockville, MD 20850, USA.
Ting WangDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63108, USA; The Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63108, USA. Electronic address: twang@wustl.edu.
Washington University in St. Louis · US

Funding

THE WASHU TARGET ENVIRONMENTAL EPIGENOMICS DATA COORDINATION CENTERU24ES026699 · NIEHS · WASHINGTON UNIVERSITY · PI WANG, TING · 2016 to 2021
$5.2M
RESEARCH EDUCATION PROGRAM ON COMPUTATIONAL AND STATISTICAL TOOL DEVELOPMENT FOR ADDICTION GENETICSR25DA027995 · NIDA · WASHINGTON UNIVERSITY · PI MADDEN, PAMELA ANN, RICE, JOHN P. · 2009 to 2019
$4.3M
DECODING THE IMPACT OF TRANSPOSABLE ELEMENTS ON GENE REGULATIONR01HG007175 · NHGRI · WASHINGTON UNIVERSITY · PI WANG, TING · 2014 to 2021
$2.7M
Connecting transposable elements and regulatory innovation using ENCODE dataU01HG009391 · NHGRI · WASHINGTON UNIVERSITY · PI COHEN, BARAK A, FESCHOTTE, CEDRIC · 2017 to 2021
$2.4M
The WashU 4DN Network Data Coordination and Integration CenterU01CA200060 · NCI · WASHINGTON UNIVERSITY · PI WANG, TING · 2015 to 2019
$1.9M
ADVANCED EPI/GENOME BROWSER WITH ENHANCED VISUALIZATION AND ANALYSIS TOOLSR01HG007354 · NHGRI · WASHINGTON UNIVERSITY · PI WANG, TING · 2013 to 2016
$1.5M
CHARTING THE EPIGENOMIC LANDSCAPE OF HUMAN TRANSPOSABLE ELEMENTSR01ES024992 · NIEHS · WASHINGTON UNIVERSITY · PI WANG, TING · 2014 to 2015
$342k
HLS-Applying EpiX™ technology to enable ex vivo theratyping using nasal brushing samples from CF patientsR43HL144177 · NHLBI · PROPAGENIX, INC. · PI POLLOK, BRIAN ANDREW · 2018 to 2018
$263k
NCI NIH HHS U01 CA200060NHGRI NIH HHS R01 HG007175NHGRI NIH HHS R01 HG007354NHGRI NIH HHS U01 HG009391NHLBI NIH HHS R43 HL144177NIDA NIH HHS R25 DA027995NIEHS NIH HHS R01 ES024992NIEHS NIH HHS U24 ES026699
6 · The paper itself

Abstract

Despite substantial self-renewal capability in vivo, epithelial stem and progenitor cells located in various tissues expand for a few passages in vitro in feeder-free condition before they succumb to growth arrest. Here, we describe the EpiX method, which utilizes small molecules that inhibit PAK1-ROCK-Myosin II and TGF-β signaling to achieve over one trillion-fold expansion of human epithelial stem and progenitor cells from skin, airway, mammary, and prostate glands in the absence of feeder cells. Transcriptomic and epigenomic studies show that this condition helps epithelial cells to overcome stresses for continuous proliferation. EpiX-expanded basal epithelial cells differentiate into mature epithelial cells consistent with their tissue origins. Whole-genome sequencing reveals that the cells retain remarkable genome integrity after extensive in vitro expansion without acquiring tumorigenicity. EpiX technology provides a solution to exploit the potential of tissue-resident epithelial stem and progenitor cells for regenerative medicine.

Indexed as

AnimalsCell DifferentiationCell ProliferationCells, CulturedEpithelial CellsFeeder CellsGene Expression RegulationHumansIn Vitro TechniquesKeratinocytesMyosin Type IINeoplasmsp21-Activated Kinasesrho-Associated KinasesSignal TransductionSmall Molecule LibrariesMyosin Type IIp21-Activated KinasesPAK1 protein, humanrho-Associated KinasesSmall Molecule LibrariesTransforming Growth Factor betacell culture methodcell therapyepithelial stem and progenitor cellsfeeder-freePAK1/ROCK/Myosin IIregenerative medicineTGF-β

Identifiers

PMID30332641
PMCPMC6284236
OpenAlexW2896091135

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.